TITLE PAGE TITLE: Five years follow-up following two or three doses of a hepatitis B vaccine in adolescents aged 11–15 years: a randomised controlled study

AFFILIATIONS Professor, Faculty of Medicine, Vaccine & Infectious Disease Institute (WHO Collaborating Centre), Centre for the Evaluation of Vaccination, Antwerpen, Belgium 2 Ministry of Health, Centre of Immunobiological Products, Kiev, Ukraine 3 Centre de Santé UCL, Clos Chapelle-aux-Champs, 30/39 1200 Brussels, Belgium 4 National Centre for Immunisation Research and Surveillance, The Children’s Hospital at Westmead, NSW 2145, Australia ; and The University of Sydney, NSW, Australia 5 GlaxoSmithKline Pharmaceuticals Ltd., India GlaxoSmithKline Biologicals, Australia GlaxoSmithKline Biologicals, Singapore GlaxoSmithKline Biologicals, Wavre, Belgium Deleted: Long-term immunity